In addition, molecular features such as microsatellite instability (MSI), mutations in proto-oncogene genes like PTEN and k-RAS, and cell growth induction mutations such as FGFR2 can be used to identify endometrial carcinoma (35). This evidence concerns the gene KRAS and endometrial carcinoma.